---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-010809"
form_type: "8-K"
ticker: "ADVB"
cik: "0001941029"
company_name: "Advanced Biomed Inc."
filed_at: "2026-02-02T23:59:59+00:00"
generated_at: "2026-05-16T05:45:46.027925+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Advanced Biomed raises $248k via private placement of 4M shares at $0.062

## Summary
- Issued 4,000,000 shares of common stock at $0.062/share for total proceeds of $248,000.
- Securities Purchase Agreement entered Jan 28, 2026, closed Jan 29, 2026.
- Private placement exempt from registration under Section 4(a)(2) of Securities Act and Regulation S.

## SEC filing metadata
- accession: 0001213900-26-010809
- form_type: 8-K
- ticker: ADVB
- cik: 0001941029
- company_name: Advanced Biomed Inc.
- filed_at: 2026-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1941029/000121390026010809/0001213900-26-010809-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1941029/000121390026010809/ea0274958-8k_advanced.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-010809
- JSON: https://secwatch.observer/filing/0001213900-26-010809.json
- Plain text: https://secwatch.observer/filing/0001213900-26-010809.txt

## Key facts
- Equity Issuances
  Advanced Biomed Inc. issued 4,000,000 shares of common stock to certain investors for $0.062 per share for a total purchase price of $248,000.
  - Security: common stock
  - Shares: 4,000,000 shares
  - Purchaser: certain investors
  - Consideration: $0.062 per share for a total purchase price of $248,000
  source text: On January 28, 2026, Advanced Biomed Inc., a Nevada Corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) relating to the issuance and sale of 4,000,000 shares of common stock (the “Purchased Shares”), par value $0.001 per share, of the Company (the “Common Stock”), at $0.062 per share for a total purchase price of $248,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1941029/000121390026010809/0001213900-26-010809-index.htm
- Material Agreements
  Advanced Biomed Inc. entered into Securities Purchase Agreement with certain investors valued at $248,000 (effective 2026-01-28).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain investors
  - Value: $248,000
  - Effective: 2026-01-28
  source text: On January 28, 2026, Advanced Biomed Inc., a Nevada Corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) relating to the issuance and sale of 4,000,000 shares of common stock (the “Purchased Shares”), par value $0.001 per share, of the Company (the “Common Stock”), at $0.062 per share for a total purchase price of $248,000 (the “Purchase Price”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1941029/000121390026010809/0001213900-26-010809-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.